Skip to content
10-Q

Quarterly Report

AYALA PHARMACEUTICALS, INC.

0001493152-23-018686

← back to feed
Filed
May 23, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 23, 2023 4.84M sh
Stock Issued Q1 2023 · Mar 31, 2023 0.19 sh
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$6.74M
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$9.98M
Short Term Investments Q1 2023 · Mar 31, 2023 $108K
Short Term Investments Q1 2023 · Dec 31, 2022 $110K
Cash And Equivalents Q1 2023 · Mar 31, 2023 $16.84M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $2.41M
Cash And Equivalents Q1 2023 · Mar 31, 2022 $27.05M
Stockholders Equity Q1 2023 · Mar 31, 2023 $9.68M
Stockholders Equity Q1 2023 · Dec 31, 2022 −$1.1M
Stockholders Equity Q1 2023 · Mar 31, 2022 $24.89M
Stockholders Equity Q1 2023 · Dec 31, 2021 $34.16M
Current Liabilities Q1 2023 · Mar 31, 2023 $9.83M
Current Liabilities Q1 2023 · Dec 31, 2022 $7.54M
Current Assets Q1 2023 · Mar 31, 2023 $18.26M
Current Assets Q1 2023 · Dec 31, 2022 $3.19M
Total Assets Q1 2023 · Mar 31, 2023 $21M
Total Assets Q1 2023 · Dec 31, 2022 $7.77M
Eps Basic Q1 2023 · Mar 31, 2023 −$1.67
Eps Basic Q1 2023 · Mar 31, 2022 −$3.47
Sga Expense Q1 2023 · Mar 31, 2023 $4.6M
Sga Expense Q1 2023 · Mar 31, 2022 $2.43M
Rd Expense Q1 2023 · Mar 31, 2023 $7.27M
Rd Expense Q1 2023 · Mar 31, 2022 $7.5M
Net Income Q1 2023 · Mar 31, 2023 −$7.36M
Net Income Q1 2023 · Mar 31, 2022 −$9.95M
Operating Income Q1 2023 · Mar 31, 2023 −$11.87M
Operating Income Q1 2023 · Mar 31, 2022 −$9.85M
Cost Of Revenue Q1 2023 · Mar 31, 2023 $4K
Cost Of Revenue Q1 2023 · Mar 31, 2022 $368K
Gross Profit Q1 2023 · Mar 31, 2022 $90K